Oscar Health, Inc. (NYSE:OSCR) Receives Average Recommendation of "Hold" from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have earned an average recommendation of "Hold" from the eight research firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $20.21.

Several equities analysts have recently weighed in on the stock. Jefferies Financial Group started coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective for the company. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th.

Oscar Health Price Performance

OSCR traded down $0.17 during trading on Friday, reaching $13.14. The stock had a trading volume of 3,910,568 shares, compared to its average volume of 3,758,802. The stock has a 50 day moving average of $14.85 and a two-hundred day moving average of $16.00. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $3.29 billion, a price-to-earnings ratio of -656.42 and a beta of 1.75. Oscar Health has a 1-year low of $12.43 and a 1-year high of $23.79.

Remove Ads

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities analysts anticipate that Oscar Health will post 0.69 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in OSCR. Tower Research Capital LLC TRC boosted its stake in Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after purchasing an additional 4,185 shares during the period. KBC Group NV lifted its holdings in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after purchasing an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health in the fourth quarter worth $100,000. Alberta Investment Management Corp purchased a new position in shares of Oscar Health during the fourth quarter valued at $138,000. Finally, Virtu Financial LLC acquired a new position in Oscar Health during the fourth quarter valued at $140,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.